- Home
- PMCB vs VRME Comparison
PMCB vs VRME Comparison
Compare PMCB & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- VRME
- Stock Information
- Founded
- PMCB 1996
- VRME 1999
- Country
- PMCB United States
- VRME United States
- Employees
- PMCB N/A
- VRME N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- VRME EDP Services
- Sector
- PMCB Health Care
- VRME Technology
- Exchange
- PMCB Nasdaq
- VRME Nasdaq
- Market Cap
- PMCB 11.4M
- VRME 9.9M
- IPO Year
- PMCB N/A
- VRME N/A
- Fundamental
- Price
- PMCB $1.22
- VRME $0.76
- Analyst Decision
- PMCB
- VRME Buy
- Analyst Count
- PMCB 0
- VRME 1
- Target Price
- PMCB N/A
- VRME $1.25
- AVG Volume (30 Days)
- PMCB 14.5K
- VRME 101.4K
- Earning Date
- PMCB 03-17-2025
- VRME 05-13-2025
- Dividend Yield
- PMCB N/A
- VRME N/A
- EPS Growth
- PMCB N/A
- VRME N/A
- EPS
- PMCB 1.29
- VRME N/A
- Revenue
- PMCB N/A
- VRME $24,207,000.00
- Revenue This Year
- PMCB N/A
- VRME N/A
- Revenue Next Year
- PMCB N/A
- VRME $5.35
- P/E Ratio
- PMCB $0.93
- VRME N/A
- Revenue Growth
- PMCB N/A
- VRME N/A
- 52 Week Low
- PMCB $1.03
- VRME $0.55
- 52 Week High
- PMCB $2.42
- VRME $5.00
- Technical
- Relative Strength Index (RSI)
- PMCB 43.93
- VRME 55.66
- Support Level
- PMCB $1.15
- VRME $0.59
- Resistance Level
- PMCB $1.32
- VRME $0.65
- Average True Range (ATR)
- PMCB 0.11
- VRME 0.05
- MACD
- PMCB 0.02
- VRME 0.03
- Stochastic Oscillator
- PMCB 65.52
- VRME 100.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.